Cellectar Biosciences, Inc. (CLRB)
1.78
-0.09
(-4.81%)
USD |
NASDAQ |
Oct 02, 16:00
1.82
+0.04
(+2.25%)
After-Hours: 20:00
Cellectar Biosciences Total Liabilities (Quarterly) : 6.767M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.767M |
| March 31, 2026 | 6.403M |
| December 31, 2025 | 5.059M |
| September 30, 2025 | 5.248M |
| June 30, 2025 | 6.228M |
| March 31, 2025 | 6.407M |
| December 31, 2024 | 9.797M |
| September 30, 2024 | 20.75M |
| June 30, 2024 | 15.62M |
| March 31, 2024 | 29.03M |
| December 31, 2023 | 25.85M |
| September 30, 2023 | 16.98M |
| June 30, 2023 | 6.976M |
| March 31, 2023 | 7.504M |
| December 31, 2022 | 12.05M |
| September 30, 2022 | 6.569M |
| June 30, 2022 | 5.698M |
| March 31, 2022 | 4.791M |
| December 31, 2021 | 4.157M |
| September 30, 2021 | 3.368M |
| June 30, 2021 | 3.755M |
| March 31, 2021 | 5.289M |
| December 31, 2020 | 3.865M |
| September 30, 2020 | 4.473M |
| June 30, 2020 | 3.867M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.444M |
| December 31, 2019 | 3.191M |
| September 30, 2019 | 3.428M |
| June 30, 2019 | 3.150M |
| March 31, 2019 | 2.702M |
| December 31, 2018 | 1.793M |
| September 30, 2018 | 2.661M |
| June 30, 2018 | 2.290M |
| March 31, 2018 | 2.109M |
| December 31, 2017 | 2.117M |
| September 30, 2017 | 2.279M |
| June 30, 2017 | 1.737M |
| March 31, 2017 | 1.548M |
| December 31, 2016 | 1.785M |
| September 30, 2016 | 1.579M |
| June 30, 2016 | 1.549M |
| March 31, 2016 | 2.993M |
| December 31, 2015 | 5.947M |
| September 30, 2015 | 5.781M |
| June 30, 2015 | 6.207M |
| March 31, 2015 | 6.323M |
| December 31, 2014 | 2.674M |
| September 30, 2014 | 5.843M |
| June 30, 2014 | 8.429M |
| March 31, 2014 | 8.767M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
| Biogen, Inc. | 13.24B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 36.64M |
| Shareholders Equity (Quarterly) | 29.87M |
| Debt to Equity Ratio | 0.0513 |
| Current Ratio | 6.659 |
| Net Debt Paydown Yield | -0.92% |